Trial Profile
Phase II Study of Combination of Lenalidomide / dose metronomic cyclophosphamide / prednisone for the treatment of patients over 75 years with newly diagnosed multiple myeloma [Estudio Fase II de Combinacion de Lenalidomida/Ciclofosfamida a dosis metronomicas/Prednisona para el tratamiento de pacientes mayores de 75 anos con mieloma multiple de nuevo diagnostico].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 Aug 2011 New trial record